FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety
暂无分享,去创建一个
M. Gwinn | C. Tibbetts | S. Kleinman | H. Nakhasi | C. Atreya | J. Epstein | J. Hughes | D. Asher | Mark O Walderhaug | P. Ganz | S. Stramer | R. Dodd | R. Goodrich | P. Mied
[1] S. Slichter,et al. White blood cell inactivation after treatment with riboflavin and ultraviolet light , 2010, Transfusion.
[2] P. Mintz,et al. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology , 2010, Transfusion.
[3] B. Custer,et al. Cost‐effectiveness of screening the US blood supply for Trypanosoma cruzi , 2010, Transfusion.
[4] J. Mikovits,et al. Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome , 2009, Science.
[5] B. Custer,et al. Defining “adequate” pathogen reduction performance for transfused blood components , 2010, Transfusion.
[6] G. Foster,et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing , 2010, Transfusion.
[7] S. Wessely,et al. Comment on “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome” , 2010, Science.
[8] Clark Tibbetts,et al. Resequencing Pathogen Microarray (RPM) for prospective detection and identification of emergent pathogen strains and variants , 2010, Defense + Commercial Sensing.
[9] E. Vamvakas,et al. Blood Still Kills: Six Strategies to Further Reduce Allogeneic Blood Transfusion-Related Mortality , 2010, Transfusion Medicine Reviews.
[10] D. Metzgar,et al. Single Assay for Simultaneous Detection and Differential Identification of Human and Avian Influenza Virus Types, Subtypes, and Emergent Variants , 2010, PloS one.
[11] J. Hess,et al. The expanding range and severity of babesiosis , 2010, Transfusion.
[12] S. Sowemimo-Coker,et al. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture–based infectivity assay , 2009, Transfusion.
[13] J. Brownstein,et al. Digital disease detection--harnessing the Web for public health surveillance. , 2009, The New England journal of medicine.
[14] Eleftherios Mylonakis,et al. Google trends: a web-based tool for real-time surveillance of disease outbreaks. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Glynn,et al. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. , 2009, Blood.
[16] Baochuan Lin,et al. Testing and Validation of High Density Resequencing Microarray for Broad Range Biothreat Agents Detection , 2009, PloS one.
[17] D. Krysztof,et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States , 2009, Transfusion.
[18] S. Kleinman,et al. Emerging infectious disease agents and their potential threat to transfusion safety , 2009, Transfusion.
[19] R. Benjamin,et al. TRANSFUSION-TRANSMITTED BABESIA MICROTI IDENTIFIED THROUGH HEMOVIGILANCE , 2010 .
[20] S. Glynn,et al. Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen Repository. , 2009, The Journal of infectious diseases.
[21] E. Operskalski,et al. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. , 2009, The Journal of infectious diseases.
[22] D. Kessler,et al. Lack of evidence of transfusion transmission of Creutzfeldt‐Jakob disease in a US surveillance study , 2009, Transfusion.
[23] Baochuan Lin,et al. Universal Detection and Identification of Avian Influenza Virus by Use of Resequencing Microarrays , 2009, Journal of Clinical Microbiology.
[24] Jeremy Ginsberg,et al. Detecting influenza epidemics using search engine query data , 2009, Nature.
[25] David A Stenger,et al. Resequencing microarray probe design for typing genetically diverse viruses: human rhinoviruses and enteroviruses , 2008, BMC Genomics.
[26] S. Montgomery,et al. Chagas disease and the US blood supply , 2008, Current opinion in infectious diseases.
[27] R. Lanciotti,et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia , 2008, Transfusion.
[28] J. Brownstein,et al. Surveillance Sans Frontières: Internet-Based Emerging Infectious Disease Intelligence and the HealthMap Project , 2008, PLoS medicine.
[29] J. Muñoz-Jordán,et al. Dengue virus in blood donations, Puerto Rico, 2005 , 2008, Transfusion.
[30] R. Rohwer,et al. A sensitive and quantitative assay for normal PrP in plasma. , 2008, Journal of Virological Methods.
[31] Baochuan Lin,et al. A model of base-call resolution on broad-spectrum pathogen detection resequencing DNA microarrays , 2008, Nucleic acids research.
[32] S. Gad,et al. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. , 2008, Transfusion medicine reviews.
[33] J. Simons,et al. A new arenavirus in a cluster of fatal transplant-associated diseases. , 2008, The New England journal of medicine.
[34] Kate E. Jones,et al. Global trends in emerging infectious diseases , 2008, Nature.
[35] M. Khoury,et al. A navigator for human genome epidemiology , 2008, Nature Genetics.
[36] J. Allain,et al. Donation archives and prospective donor‐recipient repositories: indispensable tools for monitoring blood safety , 2007, Transfusion.
[37] Frances S. Ligler,et al. Application of Broad-Spectrum, Sequence-Based Pathogen Identification in an Urban Population , 2007, PloS one.
[38] P. Sandstrom,et al. Characterization of blood‐borne transmission of simian foamy virus , 2007, Transfusion.
[39] R. Carbonell,et al. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins , 2006, The Lancet.
[40] Suvankar Pal,et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.
[41] B. Custer,et al. Strategies for testing blood donors for West Nile virus , 2006, Transfusion.
[42] Kevin L. Russell,et al. Using a Resequencing Microarray as a Multiple Respiratory Pathogen Detection Assay , 2006, Journal of Clinical Microbiology.
[43] R. Will,et al. Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.
[44] Baochuan Lin,et al. Automated identification of multiple micro-organisms from resequencing DNA microarrays , 2006, Nucleic acids research.
[45] J. Waage,et al. Infectious Diseases: Preparing for the Future , 2006, Science.
[46] David A Stenger,et al. Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays. , 2006, Genome research.
[47] Gary J. Vora,et al. Identifying Influenza Viruses with Resequencing Microarrays , 2006, Emerging infectious diseases.
[48] J. Derisi,et al. Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant , 2006, PLoS pathogens.
[49] D. Leiby. Babesiosis and blood transfusion: flying under the radar , 2006, Vox sanguinis.
[50] Baochuan Lin,et al. Use of Resequencing Oligonucleotide Microarrays for Identification of Streptococcus pyogenes and Associated Antibiotic Resistance Determinants , 2005, Journal of Clinical Microbiology.
[51] D. Gubler,et al. Disease ecology and the global emergence of zoonotic pathogens , 2005, Environmental health and preventive medicine.
[52] Daniel R. O’Leary,et al. Epidemiology and Transmission Dynamics of West Nile Virus Disease , 2005, Emerging infectious diseases.
[53] C. Nass,et al. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion , 2005, Transfusion.
[54] P. Pellett,et al. Possible transmission of human herpesvirus‐8 by blood transfusion in a historical United States cohort , 2005, Transfusion.
[55] D. Cardo,et al. Transmission of rabies virus from an organ donor to four transplant recipients. , 2005, The New England journal of medicine.
[56] M. Gilbert,et al. Ecological sources of zoonotic diseases. , 2004, Revue scientifique et technique.
[57] L. Madoff. ProMED-mail: an early warning system for emerging diseases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] D. Metzgar,et al. Use of Oligonucleotide Microarrays for Rapid Detection and Serotyping of Acute Respiratory Disease-Associated Adenoviruses , 2004, Journal of Clinical Microbiology.
[59] R. Goodrich,et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light , 2004, Transfusion.
[60] R. Lanciotti,et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. , 2003, The New England journal of medicine.
[61] S. Glynn,et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening , 2003, Transfusion.
[62] B. Chesebro. Introduction to the transmissible spongiform encephalopathies or prion diseases. , 2003, British medical bulletin.
[63] R. Lanciotti,et al. Transmission of West Nile virus from an organ donor to four transplant recipients. , 2003, The New England journal of medicine.
[64] D. Asnis,et al. The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] R. Will. New variant Creutzfeldt-Jakob disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[66] R. Pinner,et al. Trends in infectious disease mortality in the United States during the 20th century. , 1999, JAMA.
[67] R. Wesley,et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.
[68] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[69] S. Roberts. Blood Safety in the Age of AIDS , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] F. Steurer,et al. Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. , 1995, The Journal of parasitology.
[71] G. Nemo,et al. HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .
[72] F. Schuster,et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals , 1990, Journal of clinical microbiology.
[73] S. Azen,et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. , 1990 .
[74] J. Ryan,et al. Bovine spongiform encephalopathy: epidemiological studies , 1988, Veterinary Record.
[75] M. Baram. Report on Reports: Risk Assessment in the Federal Government: Managing the Process , 1983 .
[76] Division on Earth. Risk Assessment in the Federal Government: Managing the Process , 1983 .
[77] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[78] A. Tversky,et al. The framing of decisions and the psychology of choice. , 1981, Science.
[79] P. Daniel,et al. Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee , 1968, Science.
[80] Baruch Fischhoff,et al. Decision-Making Framework , 2019, Encyclopedia of Food and Agricultural Ethics.
[81] Oie. Influenza ant other emerging zoonotic diseases at the Human-Animal interface - FAO-OIE-WHO Joint Scientific Consultation, 27-29 April 2010, Verona, Italy , 2011 .
[82] 達也 澤崎,et al. Xenotropic Murine Leukemia Virus-related Virus , 2020, Definitions.
[83] H. Klein. How safe is blood, really? , 2010, Biologicals : journal of the International Association of Biological Standardization.
[84] J. Epstein. Alternative strategies in assuring blood safety: An overview. , 2010, Biologicals : journal of the International Association of Biological Standardization.
[85] P. Bennett,et al. vCJD Risk Assessment Calculations for a Patient with Multiple Routes of Exposure , 2009 .
[86] Baochuan Lin,et al. Universal Detection and Identification of Avian Influenza Using Resequencing , 2009 .
[87] A. Tversky,et al. Prospect theory: an analysis of decision under risk — Source link , 2007 .
[88] J. Waage,et al. Epidemiology. Infectious diseases: preparing for the future. , 2006, Science.
[89] J Mackenzie,et al. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. , 2006, Vox sanguinis.
[90] J. Kocik,et al. Preparedness against bioterrorism and re-emerging infectious diseases , 2004 .
[91] Joshua Lederberg,et al. Microbial Threats to Health: Emergence, Detection, and Response , 2003 .
[92] J. Lederberg,et al. Emerging Infectious Diseases from the Global to the Local Perspective , 2001 .
[93] Joshua Lederberg,et al. Emerging Infections: Microbial Threats to Health in the United States , 1992 .
[94] A. Tversky,et al. Prospect theory: analysis of decision under risk , 1979 .